Intelligence · Drug directory

Pipeline & Investigational Drugs

Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.

Quick answer

Pipeline & investigational drugs: NovaPharmaNews tracks 1,610 pharmaceutical drugs in this segment. Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.

1,610 drugs · Pipeline · by data quality · Page 17 of 68

  1. heparin

    DBL HEPARIN SODIUM Pfizer Australia Pty Ltd

    TGA: approved · NMPA: clinical trials

  2. high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate

    KETOCAL 4:1 LQ Talion

    TGA: approved

  3. honey bee venom

    ALBEY BEE VENOM Allergen

    TGA: approved

  4. hyaluronate sodium

    HYLO-FRESH Lacuna Pharma Pty Ltd

    TGA: approved

  5. hydromorphone

    DILAUDID Lacuna Pharma Pty Ltd

    TGA: approved · NMPA: clinical trials

  6. hydroxychloroquine

    APO- HYDROXYCHLOROQUINE Sanofi-aventis Healthcare Pty Ltd

    TGA: approved · NMPA: clinical trials

  7. hydroxyethyl starch 130/0.4 + sodium chloride

    VOLUVEN 6% Fresenius Kabi Australia Pty Limited

    TGA: approved

  8. hyoscine butylbromide

    BUSCOPAN Sanofi-aventis Healthcare Pty Ltd

    TGA: approved

  9. hypromellose

    REVIVE TEARS Alphapharm Pty Ltd

    TGA: approved

  10. ichthammol

    EGODERM CREAM Lacuna Pharma Pty Ltd

    TGA: approved

  11. ichthammol + zinc oxide

    EGODERM OINTMENT Lacuna Pharma Pty Ltd

    TGA: approved

  12. idarubicin

    ZAVEDOS SOLUTION Pfizer Australia Pty Ltd

    TGA: approved

  13. imipramine

    IMIPRAMINE (LEADING) Amdipharm Mercury (Australia) Pty Limited

    TGA: approved

  14. indacaterol + glycopyrronium

    ULTIBRO BREEZHALER 110/50 Novartis Pharmaceuticals

    TGA: approved

  15. indacaterol + glycopyrronium + mometasone

    ENERZAIR BREEZHALER Novartis Pharmaceuticals

    TGA: approved

  16. indacaterol + mometasone

    ATECTURA BREEZHALER Novartis Pharmaceuticals

    TGA: approved

  17. indometacin

    ARTHREXIN Alphapharm Pty Ltd

    TGA: approved · NMPA: clinical trials

  18. insulin aspart + insulin aspart protamine

    NOVOMIX 30 FLEXPEN NovoThirteen

    TGA: approved

  19. insulin degludec + insulin aspart

    RYZODEG PENFILL NovoThirteen

    TGA: approved

  20. insulin isophane human

    HUMULIN NPH NovoThirteen

    TGA: approved

  21. insulin neutral human

    ACTRAPID NovoThirteen

    TGA: approved

  22. ipratropium

    ATROVENT Cipla Australia Pty Ltd

    TGA: approved

  23. irbesartan + hydrochlorothiazide

    AVAPRO HCT 300/25 Alphapharm Pty Ltd

    TGA: approved

  24. irinotecan

    IRINOTECAN ACCORD BAXTER HEALTHCARE PTY LTD

    TGA: approved · NMPA: clinical trials

Frequently asked questions

How many pipeline drugs are listed?

1,610 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.